Actiphage is ‘additional test’ farmers want to use, says Godfray TB review
Dr Berwyn Clarke, CEO of TB-test developers PBD Biotech, responds to the Godfray Review of the Government’s bovine TB strategy, which highlights the company’s Actiphage diagnostic as an additional test to help tackle the disease.
13/11/2018